These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25429713)

  • 1. Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathies.
    Satta N; Vuilleumier N
    Curr Drug Targets; 2015; 16(4):342-60. PubMed ID: 25429713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases.
    Roux-Lombard P; Pagano S; Montecucco F; Satta N; Vuilleumier N
    Clin Rev Allergy Immunol; 2013 Feb; 44(1):84-97. PubMed ID: 21188647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases.
    Carbone F; Nencioni A; Mach F; Vuilleumier N; Montecucco F
    Thromb Haemost; 2013 May; 109(5):854-68. PubMed ID: 23446994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting.
    Latif N; Baker CS; Dunn MJ; Rose ML; Brady P; Yacoub MH
    J Am Coll Cardiol; 1993 Nov; 22(5):1378-84. PubMed ID: 7901255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.
    Nussinovitch U; Shoenfeld Y
    Clin Rev Allergy Immunol; 2012 Jun; 42(3):298-308. PubMed ID: 21207192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for autoantibodies in atherogenesis.
    Iseme RA; McEvoy M; Kelly B; Agnew L; Walker FR; Handley T; Oldmeadow C; Attia J; Boyle M
    Cardiovasc Res; 2017 Aug; 113(10):1102-1112. PubMed ID: 28899001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?
    Satta N; Frias MA; Vuilleumier N; Pagano S
    Curr Pharm Des; 2019; 25(29):3128-3146. PubMed ID: 31470782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective evaluation of antibody index of human parvovirus B19 as a prognostic factor in patients with dilated and ischemic cardiomyopathy.
    Zedtwitz-Liebenstein K; Robak O; Burgmann H; Frass M
    J Med Virol; 2013 Jun; 85(6):1111-4. PubMed ID: 23588739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease.
    Nussinovitch U; Shoenfeld Y
    Clin Rev Allergy Immunol; 2013 Feb; 44(1):98-108. PubMed ID: 21207194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology.
    Meier LA; Binstadt BA
    Front Immunol; 2018; 9():911. PubMed ID: 29755478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-KCNQ1 K⁺ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy.
    Li J; Seyler C; Wiedmann F; Schmidt C; Schweizer PA; Becker R; Katus HA; Thomas D
    Cardiovasc Res; 2013 Jun; 98(3):496-503. PubMed ID: 23447643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune features in atherosclerotic ischemic cardiomyopathy.
    Fiorito S; Magrini L
    Allerg Immunol (Paris); 1992 Nov; 24(9):336-41. PubMed ID: 1285843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoimmunotherapy to treat ischaemic heart disease.
    Duivenvoorden R; Senders ML; van Leent MMT; Pérez-Medina C; Nahrendorf M; Fayad ZA; Mulder WJM
    Nat Rev Cardiol; 2019 Jan; 16(1):21-32. PubMed ID: 30209355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoadsorption therapy in dilated cardiomyopathy.
    Felix SB; Beug D; Dörr M
    Expert Rev Cardiovasc Ther; 2015 Feb; 13(2):145-52. PubMed ID: 25494978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis in Sjögren's syndrome: evidence, possible mechanisms and knowledge gaps.
    Valim V; Gerdts E; Jonsson R; Ferreira GA; Brokstad KA; Brun JG; Midtbø H; Mydel PM
    Clin Exp Rheumatol; 2016; 34(1):133-42. PubMed ID: 26812164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis and autoimmunity: a growing relationship.
    Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
    Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy.
    Tentolouris C; Tousoulis D; Antoniades C; Bosinakou E; Kotsopoulou M; Trikas A; Toutouzas P; Stefanadis C
    Int J Cardiol; 2004 Apr; 94(2-3):301-5. PubMed ID: 15093997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy.
    Shmilovich H; Danon A; Binah O; Roth A; Chen G; Wexler D; Keren G; George J
    Int J Cardiol; 2007 Apr; 117(2):198-203. PubMed ID: 16887211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of Atherosclerosis, Clinical Characteristics, and Treatment Patterns in Heart Failure: A Case-Control Study of Middle-Aged Adult Heart Failure Patients in Rural Kenya.
    Bloomfield GS; DeLong AK; Akwanalo CO; Hogan JW; Carter EJ; Aswa DF; Binanay C; Koech M; Kimaiyo S; Velazquez EJ
    Glob Heart; 2016 Mar; 11(1):97-107. PubMed ID: 27102027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.